Skip to content

Evaluating Lanolin for the Treatment of Nipple Pain Among Breastfeeding Women

A Randomized Controlled Trial Evaluating Lanolin for the Treatment of Nipple Pain Among Breastfeeding Women

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01420419
Acronym
LanP
Enrollment
186
Registered
2011-08-19
Start date
2011-05-31
Completion date
2012-03-31
Last updated
2013-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

nipple pain, breastfeeding, nipple damage, lanolin, clinical trial

Brief summary

The purpose of this study is to evaluate the effectiveness of lanolin for the treatment of painful/damaged nipples among breastfeeding women, and to evaluate if the use of lanolin has an effect on breastfeeding outcomes such as duration and exclusivity.

Interventions

OTHERLanolin

Pea-sized amount of lanolin applied to each nipple after every breastfeeding session (approximately 8-12 times daily) until complete resolution of nipple pain and damage for a maximum of 7 days.

OTHERStandard (usual) in-hospital and community postpartum care

Women randomized to standard care will not receive lanolin or information regarding how to use lanolin. In-hospital standard care may include any of the following pain management measures at the recommendation / discretion of the participant's health care provider, or based on the patient's personal preference: analgesics (such as ibuprofen or acetaminophen); application of cold or warm compresses; application of ice packs; use of breast shields; air drying the nipples; or applying expressed breast milk.

Sponsors

University of Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Maternal complaint of nipple pain with any sign of nipple trauma to one or both nipples, such as blistering, crusting, redness, bleeding, swelling, cracking, discoloration or peeling. * Infant delivered at, or greater than 37 weeks gestation. * Singleton birth. * Speaks and understands English. * Access to telephone.

Exclusion criteria

* Infant not expected to be discharged home with mother. * Infant with congenital abnormalities that would impair breastfeeding. * Maternal allergy to lanolin. * Maternal health conditions that may interfere with breastfeeding (physical or mental illness) as determined by hospital staff.

Design outcomes

Primary

MeasureTime frameDescription
Nipple pain severity4 days post randomizationMeasured with a 10-point numeric rating scale (NRS)

Secondary

MeasureTime frameDescription
Breastfeeding duration4 and 12 weeks postpartumMeasured by asking women the last time their infant was breastfed. Breastfeeding duration will be calculated as the difference between the infant's date of birth, and the last day (date) the infant was breastfed.
Breastfeeding exclusivity4 and 12 weeks postpartumMeasured with Labbok & Krasovek's framework for breastfeeding definition (Studies in Family Planning, 1990;21(4),226-230)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026